New cancer vaccine to stop disease before it takes hold in the body - Pharmaceutical giant GSK and the University of Oxford ...

A new cancer vaccine is being developed which scientists hope could target the disease before it takes hold. The University ...

Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from ...

The partnership between the pharmaceutical giant and the university aims to create a vaccine or vaccines which target cells ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Drugmakers are growing frustrated with the National Health Service after a clawback tax unexpectedly soared, with ...

The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as threats ...

Bullish option flow detected in GSK (GSK) Pharma with 3,057 calls trading, 1.1x expected, and implied vol increasing over 4 points to 29.80%. Feb-25 34 calls and 1/31 weekly 34 calls are the most ...

Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

Swiss biopharma company BioVersys said on Tuesday it plans to list on the Swiss stock exchange in the first quarter with an initial public offering that aims to raise around 80 million Swiss francs ...

MHRA’s independence also questioned during Commons debate, with regulator accused of being too close to companies it ...